Výsledky vyhledávání - "H., Goldschmidt"

Akademický článek

Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy

Autor: Jerome H. Goldschmidt, Wan-Yu Tseng, Yunfei Wang, Janet Espirito, Anupama Vasudevan, Michelle Silver, Jackie Kwong, Ruchit Shah, Elizabeth Marrett

Publikováno v: Drugs - Real World Outcomes, Vol 11, Iss 3, Pp 425-439 (2024)

Abstract Background For patients with metastatic non-small cell lung cancer, timely molecular testing is essential to determine the appropriate course of therapy. Initial treatment with platinum chemotherapy and/or an immune checkpoint inhibitor (ICI

Externí odkaz: https://doaj.org/article/06bccd3f99814b6fa7f9c8888da41661

Zobrazit plný text záznamu

Akademický článek

Real‐world outcomes of 18,186 metastatic solid tumor outpatients: Baseline blood cell counts correlate with survival after immune checkpoint inhibitor therapy

Autor: Jerome H. Goldschmidt, Lin‐Na Chou, Philip K. Chan, Liwei Chen, Nicholas Robert, Joyce Kinsey, Katherine Pitts, Matt Nestor, Edwin P. Rock, Hillard M. Lazarus

Publikováno v: Cancer Medicine, Vol 12, Iss 22, Pp 20783-20797 (2023)

Abstract Background Patient survival in advanced/metastatic melanoma, non‐small cell lung cancer (NSCLC), and renal cell carcinoma (RCC) has improved with immune checkpoint inhibitors (ICI). Biomarkers' role in prognosis and treatment has been limi

Externí odkaz: https://doaj.org/article/bcd408a5dd8c4136bb20c543a07474f6

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting

Autor: Shirish M. Gadgeel, Pragya Rai, Srinivas Annavarapu, Sartaj Alam, Jerome H. Goldschmidt, Howard (Jack) West, Melissa Santorelli, Renata Eiras Martins

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

BackgroundThis study investigated real-world time on treatment (rwToT) and overall survival (OS) for patients with metastatic non-small cell lung cancer (mNSCLC) who initiated first-line (1L) pembrolizumab monotherapy. We also explored discontinuatio

Externí odkaz: https://doaj.org/article/9b3a9a0770cd434b8b46c82596f9dd6b

Zobrazit plný text záznamu

Akademický článek

An artificial intelligence-based 3D-segmentation assessment of sarcopenia utilizing whole-body computed tomography in patients with multiple myeloma

Autor: U. Dapunt, T. Nonnenmacher, S. Zschäbitz, M. Burghardt, M. Hajiyianni, E.K. Mai, M.S. Raab, C. Müller-Tidow, H.U. Kauczor, H. Goldschmidt, T.D. Do

Publikováno v: Brain and Spine, Vol 4, Iss , Pp 104010- (2024)

Externí odkaz: https://doaj.org/article/d67e31d9967d43d6bbac66b0c11b8211

Zobrazit plný text záznamu

H – Goldschmidt Abstracts 2013

Autor: Simon Turner, Ralf Gertisser, Janne Blichert-Toft, Colin G. Macpherson, Heather Handley

Publikováno v: Mineralogical Magazine. 77:1239-1351

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::50431874642dc11e0deb700230a93c64
https://doi.org/10.1180/minmag.2013.077.5.8

Zobrazit plný text záznamu

Akademický článek

Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)

Autor: Ran Jin, Adesuwa S. Ogbomo, Neil A. Accortt, Lincy S. Lal, Geetanjali Bishi, Darcie Sandschafer, Jerome H. Goldschmidt

Publikováno v: Therapeutic Advances in Medical Oncology, Vol 15 (2023)

Background: Bevacizumab-awwb (MVASI ® ) was the first U.S. Food and Drug Administration-approved biosimilar to Avastin ® (reference product [RP]) for the treatment of several different types of cancers, including metastatic colorectal cancer (mCRC)

Externí odkaz: https://doaj.org/article/1e3bd947becc4f728269150e570d3bc4

Zobrazit plný text záznamu